ENDOTAK RELIANCE
Report
- Report Number
- 2124215-2014-14275
- Event Type
- Injury
- Date Received
- October 1, 2014
- Date of Event
- July 10, 2014
- Report Date
- July 25, 2014
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVY
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
(B)(4). THE PRODUCT HAS BEEN RECEIVED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON COMPLETION OF ANALYSIS.
(B)(4). THIS LEAD HAS BEEN RETURNED. BOSTON SCIENTIFIC HAS CONCLUDED IT IS UNLIKELY THAT LEAD CHARACTERISTICS CAUSED OR CONTRIBUTED TO THE REPORTED CLINICAL OBSERVATIONS. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND RIGHT VENTRICULAR (RV) LEAD EXHIBITED HIGH OUT OF RANGE SHOCK IMPEDANCE MEASUREMENTS GREATER THAN 125 OHMS, LOW OUT OF RANGE SHOCK IMPEDANCE MEASUREMENTS LESS THAN 20 OHMS AND DECREASED R-WAVE MEASUREMENTS. ADDITIONALLY, RV UNDERSENSING AND OVERSENSING WAS OBSERVED THAT RESULTED IN INAPPROPRIATE ANTI-TACHYCARDIA PACING (ATP) AND SHOCK THERAPY. THE LEAD WAS OBSERVED TO HAVE DISLODGED. IT WAS REPORTED THAT THE PATIENT SUFFERED FROM TWIDDLER'S SYNDROME. AN INVASIVE PROCEDURE WAS PERFORMED. THE RV LEAD WAS EXPLANTED AND REPLACED AND THIS ICD REMAINS IMPLANTED AND IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 613105 | ENDOTAK RELIANCE | NVY | CPI - DEL CARIBE | 0293 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 71 YR | Hospitalization| L| R | 0293| E140 |